Posterior Reversible Encephalopathy Syndrome Following Chemotherapy and Immune Checkpoint Inhibitor Combination in a Patient with Small-Cell Lung Cancer

Posterior Reversible Encephalopathy Syndrome Following Chemotherapy and Immune Checkpoint Inhibitor Combination in a Patient with Small-Cell Lung Cancer

Posterior reversible encephalopathy syndrome (PRES) is a rare neurological complication that occurs following a sudden blood pressure increase. We report the case of a 64-year-old patient presenting PRES several hours after the administration of a combination of chemotherapy and a checkpoint inhibit...

Full description

Bibliographic Details
Main Authors: Cécile Evin, Nathalie Lassau, Corinne Balleyguier, Tarek Assi, Samy Ammari
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Diagnostics
Subjects:
PRES
chemotherapy
immunotherapy
status epilepticus
diaschisis
Online Access:https://www.mdpi.com/2075-4418/12/6/1369

Internet

https://www.mdpi.com/2075-4418/12/6/1369

Similar Items